← back to database
Early-stage life-sciences investing in novel, disruptive biopharmaceutical and medical-technology companies, supporting scientific breakthroughs from company creation through commercialization.
Stage focus
Specialization
Generalist / Specialist
Specialist
Latest fund size
$375 million (Lightstone Ventures III)
Latest fund vintage
2021
Investing team
Caroline GaynorPartner
Christina IsacsonPartner
Hank PlainFounding Partner
- Hanson Gifford IIIPartner
Jean GeorgeManaging Partner
Jingjing WangVice President
Mike CarusiManaging Partner